Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →GFL reported a strong Q2 FY25 with consolidated revenue of INR 1,188 crore (+25% YoY), EBITDA of INR 295 crore (+80% YoY), and PAT of INR 125 crore (+133% YoY).
✓ Verified against BSE filing
GFL reported a strong Q2 FY25 with consolidated revenue of INR 1,188 crore (+25% YoY), EBITDA of INR 295 crore (+80% YoY), and PAT of INR 125 crore (+133% YoY). EBITDA margin improved to 25% (+300bps QoQ) driven by a shift to high-value fluoropolymer grades and exit from low-end segments. The fluoropolymer segment saw margin expansion despite flat QoQ revenue, supported by new qualifications in automotive (ethanol blending) and semiconductor/EV sectors. The legacy player exit by December 2024 is expected to boost volumes from Q1 FY26. The battery materials subsidiary (GFCL EV) raised INR 1,000 crore at a valuation of INR 25,000 crore, with commercial supplies expected from Q4 FY25. Management guided for cumulative CapEx of INR 5,000 crore by FY27 and INR 6,000 crore by FY28 for EV, targeting 2x asset turnover and 25% EBITDA margins at optimal utilization. Risks include slower-than-expected ramp-up in EV business and persistent Chinese competition in commodity chemicals.
GFL ने दूसरी तिमाही में अच्छा प्रदर्शन किया। कंपनी की कुल कमाई 1,188 करोड़ रुपये रही, जो पिछले साल से 25% ज्यादा है। मुनाफा 125 करोड़ रुपये रहा, जो 133% बढ़ा। कंपनी ने महंगे फ्लोरोपॉलीमर उत्पादों पर ध्यान केंद्रित किया और सस्ते उत्पादों को बंद किया, जिससे मुनाफा बढ़ा। ऑटोमोबाइल और सेमीकंडक्टर क्षेत्रों में नए ऑर्डर मिले। दिसंबर 2024 तक एक पुरानी कंपनी के बाजार छोड़ने से अगले साल बिक्री बढ़ने की उम्मीद है। बैटरी मटेरियल बनाने वाली सहायक कंपनी ने 1,000 करोड़ रुपये जुटाए और अगली तिमाही से सप्लाई शुरू करेगी। कंपनी 2027 तक 5,000 करोड़ और 2028 तक 6,000 करोड़ रुपये निवेश करेगी। जोखिमों में ईवी कारोबार की धीमी शुरुआत और चीनी प्रतिस्पर्धा शामिल है।
0 delivered, 0 close, 1 missed.
View Promises →Slower-than-expected EV business ramp-up
View Risks →Full transcript text is available on this route.
Read Transcript →Improved from 22% in Q1 FY25 due to better product mix in fluoropolymers.
Raised at equity valuation of INR 25,000 crore for battery materials subsidiary.
Includes investments in LiPF6, electrolyte, PVDF binder, and LFP cathode.
Exit of a legacy fluoropolymer player by Dec 2024 to boost high-value grade volumes.
Management reiterated guidance for GFCL EV to achieve 2x asset turnover and 25% EBITDA margins once capacities reach optimal utilization levels.
The company plans to invest INR 5,000 crore by FY27 and INR 6,000 crore by FY28 in the battery materials business, funded through equity and internal accruals.
Driven by fluoropolymer growth, refrigerant price recovery, and EV ramp-up, management expects a significant improvement in overall performance from Q4 FY25.
Management expects initial commercial supplies of battery materials (salt, electrolyte, etc.) to start from Q4 FY25, following customer qualifications.
Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.
The LFP plant is expected to be commissioned in the third quarter of this financial year.
Management expects to substantially utilize new fluoropolymer capacities by Q4 FY25.
Battery materials qualification and commercial agreements may take longer than anticipated, delaying revenue and profitability from the EV segment.
Despite expectations, the redistribution of volumes from the exiting legacy player may not result in a proportional market share gain for GFL due to competition from other players.
Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.
Shipping delays via Cape of Good Hope caused ~INR 70-80 crore revenue deferment in Q1; may persist.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
LiPF6, electrolyte, and PVDF binder commercial supplies expected to commence from Q4 FY2025.
Mentioned in Q3 FY24, Q4 FY24
Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.
Mentioned in Q1 FY24, Q3 FY24
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
Mentioned in Q3 FY24, Q4 FY24
Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.
Management reiterated guidance for GFCL EV to achieve 2x asset turnover and 25% EBITDA margins once capacities reach optimal utilization levels.
Battery materials qualification and commercial agreements may take longer than anticipated, delaying revenue and profitability from the EV segment.
View Risks →